TPG joins hand with Abu Dhabi Investment Authority to back the transaction, JP Morgan is deal adviser. : UPL Ltd announced on Friday that its wholly-owned subsidiary, UPL Corporation Ltd, has signed a definitive agreement with Platform Specialty Products Corporation to acquire ArystaLifeScience Inc. and its subsidiaries for a cash consideration of about $4.2 billion. Tokyo-headquartered ArystaLifeScience is a global provider of innovative crop protection solutions, including bio-solutions and seed treatment. A wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA) and TPG have partnered with UPL Corp to support the proposed acquisition.